RxDoctor Payments Data

Carmen Hughes

Family · Bowling Green, KYNPI 1932750213

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.3% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,110 and has fallen 96.2% since, to $42 in 2025.

$1,896in general payments, 2019–2025

Across 140 payments — averaging $13.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$293
  • Novo Nordisk$273
  • Takeda Pharmaceuticals U.S.A., Inc.$215
  • Biohaven Pharmaceutical Holding Company Ltd.$181
  • Bayer$158
  • Biohaven Pharmaceuticals, Inc.$122
  • plus $654 from 22 others

What the payments were for

  • Food & beverage$1,88299%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,896 in reported general payments places this provider in the 75th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metformin Hcl ErMetformin Hcl13$10

Paid to pharmacies, not to this prescriber.

Other family in Bowling Green

See the full list for Kentucky →

Where these figures come from

Is this you, or does something look wrong? →